Eltroxin 100 microgram Tablets

Land: Irland

Språk: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv ingrediens:

Levothyroxine sodium

Tilgjengelig fra:

Mercury Pharma Group Ltd

ATC-kode:

H03AA; H03AA01

INN (International Name):

Levothyroxine sodium

Dosering :

100 microgram(s)

Legemiddelform:

Tablet

Resept typen:

Product subject to prescription which may be renewed (B)

Terapeutisk område:

Thyroid hormones; levothyroxine sodium

Autorisasjon status:

Marketed

Autorisasjon dato:

1995-09-18

Informasjon til brukeren

PACKAGE LEAFLET: INFORMATION FOR THE USER
ELTROXIN™ 25, 50, 100 MICROGRAMS TABLETS
LEVOTHYROXINE SODIUM
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, pharmacist or
nurse.
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4
• Thyroxine is a hormone produced by the thyroid gland.
Levothyroxine is used to replace
thyroxine in people whose thyroid gland does not work properly. You
will usually need to
take this medicine for the rest of your life and must not stop taking
it, or change the dose,
without speaking to your doctor first.
• This
medicine can affect the way other medicines work (See Section 2
‘Taking other
medicines’). If you take medicines to control diabetes or warfarin
to prevent blood clots, the dose
may need to be adjusted by your doctor when you start taking Eltroxin
tablets.
• You will start off taking a low dose of this medicine (See Section
3 ‘How to take’). Your
doctor will then increase the dose gradually at 3 – 4 week intervals
until your thyroxine levels
are corrected. This will help to reduce the chance of side effects.
• You will need regular blood tests whilst you are taking this
medicine.
• These tablets can be taken by both adults and children. If you are
giving this medicine to your
child make sure you know how many and when to give the tablets (See
Section 3 ‘How to take’)
and what side effects to look out for (See Section 4 ‘Possible side
effects’).
WHAT IS IN THIS LEAFLET
1. What Eltroxin Tablets are and what they are used for
2. What you need to know before you take Eltroxin Tablets
3. How to take Eltroxin Tablets
4. Possible side eff

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Eltroxin 100 microgram Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100 micrograms anhydrous levothyroxine sodium.
Excipients with known effect: lactose monohydrate 48.86mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
A white uncoated biconvex tablet with the words ‘Eltroxin 100’
engraved on one face and with a breakline on the other
face.
The scoreline is to allow for breaking for ease of swallowing and not
to divide into equal doses.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Recommended clinical indications: Control of hypothyroidism,
congenital hypothyroidism in infants, acquired
hypothyroidism in children and juvenile myxoedema.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
A pre-therapy ECG is valuable because ECG changes due to
hypothyroidism may be confused with ECG evidence of
cardiac ischaemia. If too rapid an increase in metabolism is produced
(causing diarrhoea, nervousness, rapid pulse,
insomnia, tremors, and sometimes anginal pain where there is latent
cardiac ischaemia) dosage must be reduced, or
withheld, for a day or two, and then re-started at a lower dose level.
Initial monitoring and dose adjustments.
It is especially necessary when starting Eltroxin to establish a
maintenance dose. The timing of this blood test depends
on patients symptoms. If their symptoms have improved after starting
Eltroxin, patients should have their TSH level
measured at around 6 weeks after starting Eltroxin. If a patient still
has symptoms 2-3 weeks after starting Eltroxin,
they will need a TSH level taken earlier.
Adults_ (under 50 years age):_
Initially 50 to 100 micrograms daily, preferably taken before
breakfast or the first meal of the day. Adjust at three to
four week intervals by 50 micrograms until normal metabolism is
steadily maintained: The final daily dose may be up
to 100 to 200 micrograms. In younger patients and in the absence of
heart disease, a serum thyrox